Evidence mapPaperPMID 40542313Full record

ArticleMikrochimica acta2025

A label-free electrochemical immunosensor on gold-printed electrode for the electrochemical detection of C-reactive protein from blood samples.

Nor Syafirah Zambry, Sushmeeka Nair Prathaban, Fatimah Ibrahim, Aung Thiha, Alexandria Sonia Karajacob, Nurul Fauzani Jamaluddin, Sharifah Faridah Syed Omar, Ina Ismiarti Shariffuddin, Aidawati Bustam, Sun Tee Tay

Abstract read
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nor Syafirah ZambryDepartment of Biomedical Engineering, Faculty of Engineering, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Sushmeeka Nair PrathabanDepartment of Biomedical Engineering, Faculty of Engineering, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Fatimah IbrahimDepartment of Biomedical Engineering, Faculty of Engineering, Universiti Malaya, 50603, Kuala Lumpur, Malaysia. fatimah@um.edu.my.
Aung ThihaCentre for Innovation in Medical Engineering (CIME), Department of Biomedical Engineering, Faculty of Engineering, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Alexandria Sonia KarajacobCentre for Innovation in Medical Engineering (CIME), Department of Biomedical Engineering, Faculty of Engineering, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Nurul Fauzani JamaluddinDepartment of Biomedical Engineering, Faculty of Engineering, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Sharifah Faridah Syed OmarDepartment of Medicine, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Ina Ismiarti ShariffuddinDepartment of Anesthesiology, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Aidawati BustamDepartment of Emergency Medicine, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
Sun Tee TayCentre for Innovation in Medical Engineering (CIME), Department of Biomedical Engineering, Faculty of Engineering, Universiti Malaya, 50603, Kuala Lumpur, Malaysia. tayst@um.edu.my.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fabrication of a simple, label-free, electrochemical immunosensor for C-reactive protein (CRP) detection is presented using a custom-designed printed circuit board (PCB) gold electrode. To enhance the sensitivity of the sensing platform, the surface of the gold working electrode was modified with multi-walled carbon nanotubes (MWCNTs), leveraging its exceptional conductivity and biocompatibility. The label-free immunosensor operates on immunological principles, with anti-CRP antibodies covalently immobilized on the modified electrode to capture and quantify CRP levels, using differential pulse voltammetry (DPV). The immunosensor demonstrated high specificity to CRP, exhibiting a linear detection range of 1.25 to 80 μg/mL of CRP in 1 × PBS, and achieving a detection limit (LOD) of 0.745 µg/mL within 30 min. Notably, the immunosensor successfully detected CRP in human ethylenediaminetetraacetic acid (EDTA)-anticoagulated whole blood with a detection limit of 0.177 µg/mL, which is within the clinical range for sepsis (5 µg/mL). Furthermore, this immunosensor was able to detect CRP using only 2 µL of EDTA-anticoagulated whole blood samples. These findings highlight the potential of the CRP immunosensor platform for point-of-care (POC) testing in clinical settings, owing to its simple fabrication, ease of operation, low cost, and robust performance.

Indexed as

Biosensing TechniquesC-Reactive ProteinElectrochemical TechniquesGoldAntibodies, ImmobilizedElectrodesHumansImmunoassayLimit of DetectionNanotubes, CarbonAntibodies, ImmobilizedC-Reactive ProteinGoldNanotubes, CarbonC-reactive proteinElectrochemical immunosensorLabel-freeMulti-wall carbon nanotubesPoint-of-care

Identifiers

PMID40542313
PMCPMC12181133

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.